Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pamir Gülez is active.

Publication


Featured researches published by Pamir Gülez.


Seizure-european Journal of Epilepsy | 2005

Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus

Durgul Ozdemir; Pamir Gülez; Nedret Uran; Gürol Yendur; Tülay Kavakli; Adem Aydin

PURPOSE Continuous midazolam infusion is commonly used for the management of status epilepticus (SE). The purpose of this study was to assess the efficacy of midazolam and mortality in childhood refractory generalized convulsive SE. METHODS We included 27 children with refractory generalized convulsive SE. Midazolam was given 0.2 mg/kg as bolus, followed by 1-5 microg/kg/min as continuous infusion. Clinical data and response to treatment were recorded for each patient. RESULTS Acute symptomatic SE accounted for 52%, and central nervous system (CNS) infections were the most frequently associated etiologic condition (44%). Complete control of seizures was achieved with midazolam infusion in the 26 (96%) children within 65 min; at a mean midazolam infusion rate of 3.1 microg/kg/min. Adverse effects such as hypotension, bradycardia or respiratory depression did not occur during midazolam infusion. In one (4%) patient with acute meningoencephalitis, SE could not be controlled. Five (19%) patients died; four had acute symptomatic aetiology and one had progressive encephalopathy. CONCLUSION Midazolam is effective and safe in the control of refractory generalized convulsive SE. The response to treatment and mortality were related to the underlying aetiology.


Indian Journal of Pediatrics | 2008

A case of hypomagnesemia with secondary hypocalcemia caused by Trpm6 gene mutation

Hurşit Apa; Ertan Kayserili; Hasan Ağın; Murat Hızarcıoğlu; Pamir Gülez; Afig Berdeli

An offspring of marriage between two first cousins presented with atonic seizures developed on the 20th day of life. The physical examination of the case was normal. In laboratory results, Ca+2 level was 5,7 mg/dl, Mg+2: 0,4 mg/dl (1,3–2,1), PTH: 28,4 pg/ml (12–92), and P-: 4,5 mg/dl. The case was diagnosed as hypomagnesemia with secondary hypocalcemia (HSH) and TRPM6 gene mutation analysis revealed a homozygote mutation of E157X.


Journal of Dr. Behcet Uz Children's Hospital | 2011

Kasabach-Merritt syndrome with İnfantile hepatic hemangioendotheliomas: a case report.

Murat Hızarcıoğlu; Pamir Gülez; Fatma Tat

İnfantil hepatik hemanjio-endotelioma, bebeklik çağının en sık görülen benign hepatik vasküler tümörüdür. Kızlarda erkeklere oranla üç kat daha fazla görülür. Olguların %75’i ilk üç ayda tanı alır. Bütün dev hemajiomlar gibi Kasabach-Merritt sendromuna neden olabilen bu hastalık, klinik olarak hepatomegali, yüksek debili kalp yetmezliği ve dev hemanjiomlar ile karakterizedir. Özellikle yenidoğan ve erken sütçocukluğu döneminde şant hiperbilirubinemisi sonucu uzamış sarılığa yol açabilir. Kasabach-Merritt sendromunda dev hemanjiomlar hızlı büyüyerek yaşamı tehdit eden trombositopeni, mikroanjiopatik hemolitik anemi ve tüketim koagülopatisine yol açabilir. Bu sendromun tedavisi trombositopeni, anemi, tüketim koagülopatisinin yönetimini kapsar. Küçük lezyonları için cerrahi eksizyon uygulanabilir. Mortalite oranı yüksektir. Bu makalede uzamış sarılık nedenleri araştırılırken, Kasabach-Merritt sendromu bulguları ile karşılaşılan infantil hepatik hemanjioendoteliomalı bir olgu sunulmuştur.


Journal of Dr. Behcet Uz Children's Hospital | 2011

Evaluation of drug poisoning in children.

Pamir Gülez; Hasan Ağın; Hurşit Apa; Nesrin Gulez; Murat Hızarcıoğlu; Ertan Kayserili

Objective: The aim of this prospective study was to evaluate the pattern of acute poisoning related to drugs in children with relation to different age groups. Methods: The age, gender, active pharmaceutical ingredients, mode of drug provision, time elapsed from drug intake to the hospital entry, duration of hospitalization and the outcome of all drug-related cases of poisoning that were admitted to our hospital during 2006 were recorded. Results: A total of 257 cases, aged between 1 month and 18 years with drug-related poisoning were included in the study which comprised 2.2‰ of all emergency admissions. Among all, 80.9% of the cases were between 0-6 years of age. In 85.2% of the cases, the drugs were ingested accidentally and in 14.8% for suicidal purposes. Accidental drug ingestion was more frequent in boys and in children under the age of 6, while ingestion for suicidal purposes was more common in girls and in children over 7 years of age. The most common drug poisonings were related to drugs affecting the central nervous system (36.9%). The 5.4% of the cases were admitted to the critical care unit and 0.8% of them died. Conclusion: The study revealed that children of all ages could easily have access to drugs. Amitryptilin, an easy-to buy and low-cost drug was determined as the most common cause of drug-related poisonings.


Archive | 2004

Acil servise başvuran mantar zehirlenmelerinin retrospektif olarak incelenmesi

Çiğdem Ecevit; Murat Hızarcıoğlu; Pelin Akgün Gerçek; Hakan Gerçek; Ertan Kayserili; Pamir Gülez; Hurşit Apa


Turkiye Klinikleri Journal of Pediatric Sciences | 2005

Normal Görünümlü Müsküler Distrofili Bir Olgu

Hurşit Apa; Ertan Kayserili; Murat Hizarcioğlu; Pamir Gülez; Funda Tayfun


Archive | 2005

Çocukluk çağı yabancı cisim aspirasyonları

Hurşit Apa; Ertan Kayserili; Murat Hızarcıoğlu; Pamir Gülez; Özgür Umaç; Ayşe Gülden Diniz


Clinical and Experimental Dermatology | 2015

Delay in Diagnosis in Children with Visceral Leishmaniasis: A Single-Center Experience

Pamir Gülez; Nesrin Gulez; Fatma Devrim; Derya Birim Erdogan


Turk Pediatri Arsivi-turkish Archives of Pediatrics | 2013

Kikuchi Fujimoto hastalığı ile birlikte hemofagositik sendrom

Pamir Gülez; Murat Hızarcıoğlu; Ragıp Ortaç


Medical journal of Bakirköy | 2013

Schmid type metaphyseal chondrodysplasia

Murat Hızarcıoğlu; Pamir Gülez; Deniz Tırak; Tuna Günhan

Collaboration


Dive into the Pamir Gülez's collaboration.

Top Co-Authors

Avatar

Hurşit Apa

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Hasan Ağın

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Nedret Uran

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Suna Asilsoy

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar

Aycan Ünalp

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar

Afig Berdeli

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Fatma Devrim

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Gürol Yendur

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Ragip Ortac

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Tülay Kavakli

Boston Children's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge